NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity
المؤلفون المشاركون
Liang, Yu-Chih
Chuang, Shuang-En
Huang, Chung-Yang
Huang, Wei-Jan
Chi, Li-Ling
Lee, Chi-Yun
Lin, Chia-Wei
Chen, Ai-Ling
Chiu, Chun-Jung
Lee, Cheng-Feng
Huang, Jing-Shi
Chen, Chia-Nan
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-11، 11ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-10-20
دولة النشر
مصر
عدد الصفحات
11
التخصصات الرئيسية
الملخص EN
HDAC inhibitors (HDACis) have been developed as promising anticancer agents in recent years.
In this study, we synthesized and characterized a novel HDACi, termed NBM-HD-1.
This agent was derived from the semisynthesis of propolin G, isolated from Taiwanese green propolis (TGP), and was shown to be a potent suppressor of tumor cell growth in human breast cancer cells (MCF-7 and MDA-MB-231) and rat glioma cells (C6), with an IC50 ranging from 8.5 to 10.3 μM.
Western blot demonstrated that levels of p21(Waf1/Cip1), gelsolin, Ac-histone 4, and Ac-tubulin markedly increased after treatment of cancer cells with NBM-HD-1.
After NBM-HD-1 treatment for 1–4 h, p-PTEN and p-AKT levels were markedly decreased.
Furthermore, we also found the anticancer activities of NBM-HD-1 in regulating cell cycle regulators.
Treatment with NBM-HD-1, p21(Waf1/Cip1) gene expression had markedly increased while cyclin B1 and D1 gene expressions had markedly decreased.
On the other hand, we found that NBM-HD-1 increased the expressions of tumor-suppressor gene p53 in a dose-dependent manner.
Finally, we showed that NBM-HD-1 exhibited potent antitumor activity in a xenograft model.
In conclusion, this study demonstrated that this compound, NBM-HD-1, is a novel and potent HDACi with anticancer activity in vitro and in vivo.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Huang, Wei-Jan& Liang, Yu-Chih& Chuang, Shuang-En& Chi, Li-Ling& Lee, Chi-Yun& Lin, Chia-Wei…[et al.]. 2011. NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity. Evidence-Based Complementary and Alternative Medicine،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-1028532
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Huang, Wei-Jan…[et al.]. NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity. Evidence-Based Complementary and Alternative Medicine No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-1028532
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Huang, Wei-Jan& Liang, Yu-Chih& Chuang, Shuang-En& Chi, Li-Ling& Lee, Chi-Yun& Lin, Chia-Wei…[et al.]. NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity. Evidence-Based Complementary and Alternative Medicine. 2011. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-1028532
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1028532
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر